Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control

The purpose of this research is to prove that data generated by your real-time personal continuous glucose monitors CGMs brought in the hospital at the time of hospitalization can be monitored and safely used to guide insulin therapy aiming to improve glycemic control and to diminish the hypoglycemia and hyperglycemia episodes without negatively affecting patients' satisfaction, providers and your nurses satisfaction with how glucose is monitored and treated in the hospital.

NCT Number	NCT07006480
Lead Sponsor	Mayo Clinic
Conditions	Diabetes Mellitus
Enrollment	150 participants
Start Date	2025-10-01
Primary Completion	2027-02-09 (estimated)
Study Completion	2027-02-09 (estimated)
Updated on ClinicalTrials.gov	2026-07-15